Tropical Doctor > Volume 38, Number 3 > Pp. 159-160

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Ngoma, D. Articles by Harries, A. D Search for Related Content PubMed PubMed Citation Social Bookmarking                      What's this?

Short Reports

World Health Organization Clinical Stage 3 disease conditions in HIV-infected patients who start antiretroviral therapy in Malawi

Damas Ngoma MBChB MS   ^*   Simon D Makombe Dip clin Med      Kelita Kamoto MB MSc      Anthony D Harries MD FRCP      

^* Kamuzu Central Hospital, PO Box 45, Lilongwe; HIV Unit, Ministry of Health, PO Box 30377, Lilongwe; Family Health International, Malawi Country Office, PO Box 30455, Lilongwe, Malawi; London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK

Correspondence to: Professor AD Harries, Family Health International, Malawi Country Office, Arwa House, 3rd Floor, PO Box 30455, Lilongwe 3, Malawi Email: adharries{at}malawi.net

There is little information about disease conditions that are diagnosed in patients diagnosed as having World Health Organization Clinical Stage 3 HIV who are started on antiretroviral therapy (ART) in Africa. We therefore conducted an audit in the central region of Malawi of patients registered for ART between January and September 2006. There were 4299 patients in Stage 3 of whom 4154 had data about their disease conditions. Only one condition was listed for 3880 patients. Of these, 1892 (48.8%) had unexplained weight loss, chronic fever or chronic diarrhoea, 822 (21.2%) had active/previous tuberculosis (TB) and 671 (17.3%) had a severe presumed bacterial infection. No patient was diagnosed as having haematological abnormalities. Nearly half the patients started on ART had a symptomatic, unspecified disease, (which may be obscuring important pathologies such as TB) and almost no laboratory assessment had taken place before the commencement of ART. These two areas need to be addressed in order to improve the management of patients starting on ART.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?